Physician profile
Sarah Thayer
NPI 1477520187
$914.10
in general payments reported to CMS, 2019-2025
18 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.06 · 2021: $167 · 2022: $98.87 · 2023: $152 · 2024: $305 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.25 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $222.72 | 2021-2023 | Tukysa |
| Daiichi Sankyo INC. | $137.26 | 2023-2025 | Enhertu |
| Abbvie INC. | $92.93 | 2021-2025 | Natrelle Saline-Filled Breast Implants |
| Recordati_rare_diseases_inc. | $73.17 | 2024-2025 | Sylvant |
| Astrazeneca Pharmaceuticals Lp | $48.73 | 2024 | Enhertu |
| Merck Sharp & Dohme LLC | $48.33 | 2024 | Keytruda |
| Pfizer INC. | $40.48 | 2024-2025 | |
| Stemline Therapeutics INC. | $39.66 | 2023 | Orserdu |
| Genentech USA, INC. | $34.25 | 2023-2024 | Tecentriq, Phesgo |
| Hologic Sales and Service, LLC | $30.52 | 2025 | Magtrace, Sentimag, Magseed |
| Stryker Corporation | $21.06 | 2019 | |
| Kci USA, INC. | $21.00 | 2023 | Prevena |
| Servier Pharmaceuticals LLC | $20.51 | 2024 | |
| Tersera Therapeutics LLC | $18.96 | 2025 | Zoladex |
| Novartis Pharmaceuticals Corporation | $18.56 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.98 | 2023 | Verzenio |
| Beigene USA, INC. | $16.77 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Thayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.